<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The newly identified protein BLAP75/RMI1 associates with the helicase BLM and is critical for the function of the homologous recombination complex </plain></SENT>
<SENT sid="1" pm="."><plain>Mutations altering BLM function are associated with highly elevated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> susceptibility (<z:e sem="disease" ids="C0005859" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Bloom's syndrome</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>We have analyzed the common polymorphism Ser455Asn in RMI1 and its association with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk in <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, N=93), myelodysplatic syndromes (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, N=74), and <z:hpo ids='HP_0002861'>malignant melanoma</z:hpo> (MM, N=166) </plain></SENT>
<SENT sid="3" pm="."><plain>Two control groups were used: one population-based (N=119) and one recruited from spouses of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients (N=189) </plain></SENT>
<SENT sid="4" pm="."><plain>The results showed a consistent pattern, where carriers of the Asn variant had a significantly increased risk of <z:e sem="disease" ids="C1332153" disease_type="Neoplastic Process" abbrv="">AML/MDS</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The risk of <z:e sem="disease" ids="C1332153" disease_type="Neoplastic Process" abbrv="">AML/MDS</z:e> for SerAsn+AsnAsn subjects was odds ratio (OR)=1.7, 95% confidence interval (CI) 1.1-2.5 or MM was OR=1.5, 95% CI 1.0-2.2 </plain></SENT>
<SENT sid="6" pm="."><plain>Age might modify the effect of RMI1 on <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk </plain></SENT>
<SENT sid="7" pm="."><plain>This was most evident for MM: AsnAsn homozygotes &gt; or =64 years showed OR=2.7, 95% CI 1.1-6.0, whereas individuals &lt;64 years showed OR=0.87, 95% CI 0.31-2.5 </plain></SENT>
<SENT sid="8" pm="."><plain>These results indicate a role of low-penetrance genes involved in BLM-associated homologous recombination for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk </plain></SENT>
</text></document>